Trade Fulgent Genetics, Inc. - FLGT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.12 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004012% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Fulgent Genetics Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 27.53 |
Open* | 27.01 |
1-Year Change* | -25.35% |
Day's Range* | 27.01 - 27.78 |
52 wk Range | 23.09-44.09 |
Average Volume (10 days) | 189.06K |
Average Volume (3 months) | 5.09M |
Market Cap | 810.17M |
P/E Ratio | -100.00K |
Shares Outstanding | 29.63M |
Revenue | 286.41M |
EPS | -2.14 |
Dividend (Yield %) | N/A |
Beta | 1.56 |
Next Earnings Date | Feb 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 1, 2023 | 27.43 | 0.11 | 0.40% | 27.32 | 27.78 | 26.98 |
Nov 30, 2023 | 27.53 | -0.05 | -0.18% | 27.58 | 27.93 | 27.25 |
Nov 29, 2023 | 27.51 | 0.01 | 0.04% | 27.50 | 28.12 | 27.40 |
Nov 28, 2023 | 27.48 | 0.07 | 0.26% | 27.41 | 27.60 | 27.17 |
Nov 27, 2023 | 27.53 | -0.02 | -0.07% | 27.55 | 27.70 | 27.27 |
Nov 24, 2023 | 27.78 | 0.32 | 1.17% | 27.46 | 28.04 | 27.46 |
Nov 22, 2023 | 27.43 | 0.11 | 0.40% | 27.32 | 27.88 | 27.25 |
Nov 21, 2023 | 27.25 | -0.20 | -0.73% | 27.45 | 27.60 | 27.14 |
Nov 20, 2023 | 27.55 | 0.79 | 2.95% | 26.76 | 27.89 | 26.72 |
Nov 17, 2023 | 27.00 | -0.31 | -1.14% | 27.31 | 27.74 | 26.93 |
Nov 16, 2023 | 27.58 | 0.30 | 1.10% | 27.28 | 27.67 | 26.95 |
Nov 15, 2023 | 27.49 | 0.51 | 1.89% | 26.98 | 27.81 | 26.98 |
Nov 14, 2023 | 27.27 | 0.82 | 3.10% | 26.45 | 27.46 | 26.45 |
Nov 13, 2023 | 26.19 | 0.38 | 1.47% | 25.81 | 26.55 | 25.38 |
Nov 10, 2023 | 26.12 | 0.17 | 0.66% | 25.95 | 26.50 | 25.75 |
Nov 9, 2023 | 26.03 | -0.23 | -0.88% | 26.26 | 26.76 | 25.96 |
Nov 8, 2023 | 26.37 | 0.32 | 1.23% | 26.05 | 26.93 | 26.05 |
Nov 7, 2023 | 26.45 | -0.44 | -1.64% | 26.89 | 27.17 | 26.33 |
Nov 6, 2023 | 27.05 | 0.10 | 0.37% | 26.95 | 27.52 | 26.61 |
Nov 3, 2023 | 26.85 | 2.63 | 10.86% | 24.22 | 27.41 | 24.22 |
Fulgent Genetics, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, February 26, 2024 | ||
Time (UTC) 21:00 | Country US
| Event Q4 2023 Fulgent Genetics Inc Earnings Release Q4 2023 Fulgent Genetics Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 618.968 | 992.584 | 421.712 | 32.528 | 21.351 |
Revenue | 618.968 | 992.584 | 421.712 | 32.528 | 21.351 |
Cost of Revenue, Total | 252.067 | 215.533 | 89.807 | 14.107 | 10.697 |
Gross Profit | 366.901 | 777.051 | 331.905 | 18.421 | 10.654 |
Total Operating Expense | 440.441 | 316.631 | 135.908 | 32.956 | 26.421 |
Selling/General/Admin. Expenses, Total | 149.992 | 75.171 | 30.167 | 12.312 | 10.19 |
Research & Development | 28.91 | 24.219 | 11.58 | 6.537 | 5.534 |
Operating Income | 178.527 | 675.953 | 285.804 | -0.428 | -5.07 |
Interest Income (Expense), Net Non-Operating | 5.498 | 1.347 | 1.526 | 0.837 | 0.434 |
Net Income Before Taxes | 184.025 | 677.3 | 287.33 | 0.409 | -4.636 |
Net Income After Taxes | 141.923 | 502.505 | 214.798 | 0.366 | -4.672 |
Net Income Before Extra. Items | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Total Extraordinary Items | 0 | ||||
Net Income | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Income Available to Common Excl. Extra. Items | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Income Available to Common Incl. Extra. Items | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Dilution Adjustment | |||||
Diluted Net Income | 143.403 | 507.364 | 214.31 | -0.411 | -5.607 |
Diluted Weighted Average Shares | 30.964 | 30.976 | 24.056 | 18.709 | 17.978 |
Diluted EPS Excluding Extraordinary Items | 4.63128 | 16.3793 | 8.9088 | -0.02197 | -0.31188 |
Diluted Normalized EPS | 4.70538 | 16.3793 | 9.0441 | -0.02197 | -0.31188 |
Equity In Affiliates | 0 | 3.734 | -0.488 | -0.777 | -0.935 |
Dividends per Share - Common Stock Primary Issue | |||||
Unusual Expense (Income) | 2.975 | 4.354 | |||
Depreciation / Amortization | 6.497 | 1.708 | |||
Minority Interest | 1.48 | 1.125 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 67.853 | 66.168 | 67.704 | 105.655 | 125.341 |
Revenue | 67.853 | 66.168 | 67.704 | 105.655 | 125.341 |
Cost of Revenue, Total | 47.281 | 47.357 | 54.717 | 59.56 | 60.065 |
Gross Profit | 20.572 | 18.811 | 12.987 | 46.095 | 65.276 |
Total Operating Expense | 87.651 | 90.992 | 104.256 | 105.303 | 112.547 |
Selling/General/Admin. Expenses, Total | 28.716 | 31.885 | 39.046 | 36.125 | 41.106 |
Research & Development | 9.692 | 9.782 | 8.509 | 7.507 | 6.905 |
Operating Income | -19.798 | -24.824 | -36.552 | 0.352 | 12.794 |
Interest Income (Expense), Net Non-Operating | 5.098 | 3.775 | 3.09 | 1.405 | 0.958 |
Net Income Before Taxes | -14.7 | -21.049 | -33.462 | 1.757 | 13.752 |
Net Income After Taxes | -11.59 | -15.849 | -24.076 | 1.343 | 11.099 |
Equity In Affiliates | 0 | 0 | 0 | ||
Net Income Before Extra. Items | -11.229 | -15.34 | -23.832 | 1.719 | 11.537 |
Net Income | -11.229 | -15.34 | -23.832 | 1.719 | 11.537 |
Income Available to Common Excl. Extra. Items | -11.229 | -15.34 | -23.832 | 1.719 | 11.537 |
Income Available to Common Incl. Extra. Items | -11.229 | -15.34 | -23.832 | 1.719 | 11.537 |
Diluted Net Income | -11.229 | -15.34 | -23.832 | 1.719 | 11.537 |
Diluted Weighted Average Shares | 29.813 | 29.536 | 29.62 | 30.867 | 31.189 |
Diluted EPS Excluding Extraordinary Items | -0.37665 | -0.51937 | -0.80459 | 0.05569 | 0.36991 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.37665 | -0.51937 | -0.80516 | 0.05829 | 0.44485 |
Minority Interest | 0.361 | 0.509 | 0.244 | 0.376 | 0.438 |
Depreciation / Amortization | 1.962 | 1.968 | 2.01 | 2.006 | 1.575 |
Unusual Expense (Income) | 0 | -0.026 | 0.105 | 2.896 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 627.873 | 611.96 | 523.616 | 37.079 | 39.543 |
Cash and Short Term Investments | 526.235 | 450.499 | 299.367 | 28.269 | 31.034 |
Cash & Equivalents | 79.506 | 164.894 | 87.426 | 11.965 | 6.736 |
Short Term Investments | 446.729 | 285.605 | 211.941 | 16.304 | 24.298 |
Total Receivables, Net | 90.544 | 145.011 | 204.076 | 7.245 | 7.489 |
Accounts Receivable - Trade, Net | 52.749 | 139.149 | 185.236 | 6.705 | 5.948 |
Prepaid Expenses | 6.814 | 4.244 | 3.682 | 1.288 | 0.706 |
Other Current Assets, Total | 4.28 | 12.206 | 16.491 | 0.277 | 0.314 |
Total Assets | 1386.05 | 1278.72 | 700.461 | 88.756 | 53.904 |
Property/Plant/Equipment, Total - Net | 98.921 | 71.163 | 41.027 | 8.607 | 6.446 |
Property/Plant/Equipment, Total - Gross | 142.202 | 90.793 | 51.947 | 16.597 | 12.332 |
Accumulated Depreciation, Total | -43.281 | -19.63 | -10.92 | -7.99 | -5.886 |
Long Term Investments | 326.648 | 485.047 | 132.502 | 42.819 | 7.898 |
Other Long Term Assets, Total | 38.941 | 23.739 | 3.316 | 0.251 | 0.017 |
Total Current Liabilities | 88.107 | 105.31 | 130.115 | 3.723 | 2.738 |
Accounts Payable | 23.093 | 20.494 | 26.488 | 1.581 | 1.313 |
Accrued Expenses | 24.981 | 17.689 | 8.713 | 1.753 | 1.425 |
Notes Payable/Short Term Debt | 20.638 | 21.284 | 15.019 | 0 | 0 |
Other Current Liabilities, Total | 18.452 | 45.511 | 79.895 | 0.389 | |
Total Liabilities | 119.368 | 119.971 | 131.074 | 5.979 | 2.752 |
Total Long Term Debt | 1.818 | 1.398 | 0 | 0 | 0 |
Deferred Income Tax | 9.836 | 0.725 | 0.377 | ||
Other Liabilities, Total | 16.417 | 5.407 | 0.582 | 2.256 | 0.014 |
Total Equity | 1266.69 | 1158.75 | 569.387 | 82.777 | 51.152 |
Common Stock | 0.003 | 0.003 | 0.003 | 0.002 | 0.002 |
Additional Paid-In Capital | 486.585 | 501.908 | 418.065 | 146.058 | 114.203 |
Retained Earnings (Accumulated Deficit) | 801 | 657.597 | 150.881 | -63.429 | -63.018 |
Other Equity, Total | -20.903 | -0.759 | 0.438 | 0.146 | -0.035 |
Total Liabilities & Shareholders’ Equity | 1386.05 | 1278.72 | 700.461 | 88.756 | 53.904 |
Total Common Shares Outstanding | 29.438 | 30.16 | 28.178 | 21.483 | 18.172 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Goodwill, Net | 143.027 | 50.897 | |||
Intangibles, Net | 150.643 | 35.914 | |||
Current Port. of LT Debt/Capital Leases | 0.943 | 0.332 | |||
Capital Lease Obligations | 1.818 | 1.398 | |||
Minority Interest | 3.19 | 7.131 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 549.855 | 528.289 | 580.723 | 627.873 | 696.614 |
Cash and Short Term Investments | 467.802 | 458.431 | 504.485 | 526.235 | 571.06 |
Cash & Equivalents | 84.076 | 58.348 | 66.172 | 79.506 | 168.77 |
Short Term Investments | 383.726 | 400.083 | 438.313 | 446.729 | 402.29 |
Total Receivables, Net | 69.593 | 57.026 | 64.641 | 90.544 | 109.646 |
Accounts Receivable - Trade, Net | 49.277 | 34.809 | 43.549 | 52.749 | 104.159 |
Prepaid Expenses | 7.583 | 7.301 | 6.875 | 6.814 | 8.399 |
Other Current Assets, Total | 4.877 | 5.531 | 4.722 | 4.28 | 7.509 |
Total Assets | 1358.4 | 1354.58 | 1376.77 | 1386.05 | 1405.78 |
Property/Plant/Equipment, Total - Net | 99.115 | 103.196 | 94.853 | 98.921 | 101.18 |
Property/Plant/Equipment, Total - Gross | 146.223 | 152.862 | 140.992 | 142.202 | 137.146 |
Accumulated Depreciation, Total | -47.108 | -49.666 | -46.139 | -43.281 | -35.966 |
Long Term Investments | 383.659 | 388.383 | 366.833 | 326.648 | 346.946 |
Other Long Term Assets, Total | 39.436 | 46.266 | 42.539 | 38.941 | 52.876 |
Total Current Liabilities | 61.421 | 64.819 | 81.939 | 88.107 | 102.522 |
Accounts Payable | 15.772 | 20.607 | 22.08 | 23.093 | 14.481 |
Accrued Expenses | 21.031 | 22.229 | 21.088 | 24.981 | 25.101 |
Notes Payable/Short Term Debt | 2.89 | 4.56 | 20.607 | 20.638 | 20.48 |
Other Current Liabilities, Total | 21.191 | 16.888 | 17.21 | 18.452 | 41.533 |
Total Liabilities | 99.7 | 94.814 | 112.319 | 119.368 | 128.735 |
Total Long Term Debt | 0.894 | 1.03 | 1.575 | 1.818 | 2.05 |
Deferred Income Tax | 19.388 | 9.836 | 9.836 | 9.836 | 1.826 |
Other Liabilities, Total | 14.861 | 15.566 | 14.498 | 16.417 | 17.987 |
Total Equity | 1258.7 | 1259.76 | 1264.45 | 1266.69 | 1277.05 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 |
Additional Paid-In Capital | 514.262 | 506.075 | 495.981 | 486.585 | 477.814 |
Retained Earnings (Accumulated Deficit) | 761.324 | 774.431 | 785.66 | 801 | 824.832 |
Other Equity, Total | -16.891 | -20.746 | -17.196 | -20.903 | -25.602 |
Total Liabilities & Shareholders’ Equity | 1358.4 | 1354.58 | 1376.77 | 1386.05 | 1405.78 |
Total Common Shares Outstanding | 30.035 | 29.917 | 29.692 | 29.438 | 29.681 |
Goodwill, Net | 141.844 | 141.97 | 143.12 | 143.027 | 120.313 |
Intangibles, Net | 144.489 | 146.473 | 148.699 | 150.643 | 87.853 |
Long Term Debt | |||||
Minority Interest | 3.136 | 3.563 | 4.471 | 3.19 | 4.35 |
Current Port. of LT Debt/Capital Leases | 0.537 | 0.535 | 0.954 | 0.943 | 0.927 |
Capital Lease Obligations | 0.894 | 1.03 | 1.575 | 1.818 | 2.05 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 141.923 | 506.239 | 214.31 | -0.411 | -5.607 |
Cash From Operating Activities | 253.52 | 538.577 | 140.628 | 5.517 | -0.675 |
Cash From Operating Activities | 32.662 | 11.004 | 2.962 | 2.107 | 2.163 |
Deferred Taxes | -8.28 | -8.188 | -1.775 | -0.021 | 0.036 |
Non-Cash Items | 85.21 | 32.198 | 16.582 | 4.757 | 3.977 |
Cash Taxes Paid | 56.193 | 237.069 | 20.612 | 0.02 | 0.001 |
Changes in Working Capital | 2.005 | -2.676 | -91.451 | -0.915 | -1.244 |
Cash From Investing Activities | -261.314 | -546.548 | -326.438 | -29.046 | 0.95 |
Capital Expenditures | -18.775 | -23.844 | -35.13 | -1.182 | -2.322 |
Other Investing Cash Flow Items, Total | -242.539 | -522.704 | -291.308 | -27.864 | 3.272 |
Cash From Financing Activities | -77.141 | 85.405 | 261.251 | 28.775 | 0.015 |
Financing Cash Flow Items | 0 | 0.01 | 0 | ||
Total Cash Dividends Paid | |||||
Issuance (Retirement) of Stock, Net | -76.074 | 85.406 | 246.232 | 28.775 | 0.015 |
Net Change in Cash | -85.388 | 77.468 | 75.461 | 5.229 | 0.246 |
Foreign Exchange Effects | -0.453 | 0.034 | 0.02 | -0.017 | -0.044 |
Issuance (Retirement) of Debt, Net | -1.067 | -0.011 | 15.019 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.849 | 141.923 | 165.999 | 164.656 | 153.557 |
Cash From Operating Activities | -7.907 | 253.52 | 220.313 | 199.537 | 188.411 |
Cash From Operating Activities | 6.879 | 32.662 | 22.86 | 13.04 | 4.695 |
Deferred Taxes | -5.2 | -8.28 | -4.934 | -7.639 | -5.497 |
Non-Cash Items | 11.056 | 85.21 | 57.419 | 39.227 | 20.84 |
Cash Taxes Paid | 1.68 | 56.193 | 56.181 | 54.982 | 0.435 |
Changes in Working Capital | -4.793 | 2.005 | -21.031 | -9.747 | 14.816 |
Cash From Investing Activities | -4.354 | -261.314 | -168.715 | -213.004 | 0.688 |
Capital Expenditures | -2.034 | -18.775 | -14.053 | -8.618 | -5.36 |
Other Investing Cash Flow Items, Total | -2.32 | -242.539 | -154.662 | -204.386 | 6.048 |
Cash From Financing Activities | -1.101 | -77.141 | -47.548 | -12.086 | -0.934 |
Issuance (Retirement) of Stock, Net | -0.869 | -76.074 | -46.712 | -11.488 | -0.478 |
Issuance (Retirement) of Debt, Net | -0.232 | -1.067 | -0.836 | -0.598 | -0.456 |
Foreign Exchange Effects | 0.028 | -0.453 | -0.174 | -0.561 | 0.01 |
Net Change in Cash | -13.334 | -85.388 | 3.876 | -26.114 | 188.175 |
Financing Cash Flow Items | 0 | 0 | 0 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Hsieh (Ming) | Individual Investor | 27.7788 | 8313304 | -4783 | 2023-08-01 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 10.6175 | 3177470 | -54014 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.6362 | 1387457 | 12321 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 3.4968 | 1046481 | 192932 | 2023-06-30 | LOW |
Gao (Hanlin) | Individual Investor | 2.7279 | 816365 | -1041 | 2023-09-07 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.5267 | 756161 | -42920 | 2023-06-30 | LOW |
Divisadero Street Capital Management, LP | Investment Advisor/Hedge Fund | 2.3164 | 693212 | 326712 | 2023-06-30 | HIGH |
Citadel Advisors LLC | Hedge Fund | 1.5519 | 464422 | 166247 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3784 | 412507 | 7843 | 2023-06-30 | LOW |
Nuveen LLC | Pension Fund | 1.0818 | 323754 | 176160 | 2023-06-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 0.959 | 287006 | -35209 | 2023-06-30 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.9098 | 272271 | -6081 | 2023-06-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6726 | 201297 | 21691 | 2023-06-30 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.6255 | 187200 | 16975 | 2023-06-30 | MED |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.6215 | 186004 | -4321 | 2023-06-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.5967 | 178559 | 5225 | 2023-06-30 | LOW |
Xie (Jian) | Individual Investor | 0.5783 | 173077 | -1492 | 2023-09-07 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.5256 | 157285 | -6086 | 2023-09-30 | LOW |
Principal Global Investors (Equity) | Investment Advisor | 0.3922 | 117361 | -8340 | 2023-06-30 | LOW |
Parametric Portfolio Associates LLC | Investment Advisor | 0.3852 | 115287 | -1213 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Fulgent Genetics, Inc. Company profile
Fulgent Genetics (FLGT) is a global molecular diagnostic and genetic testing services provider.
Headquartered in Temple City, California, Fulgent Genetics was founded in 2011 as Fulgent Diagnostics. The company merges the fields of genetics, molecular biology and computer science to conduct diagnostic testing and genomic sequencing.It offers flexible testing options for physicians and patients.
Fulgent Genetics’ portfolio consists of more than 18,000 single genes for genetic testing, 800 rare disease tests, complete genome sequencing, complete genome Copy Number Variation (CNVs) analysis, mitochondrial sequencing and CLIA/CAP quality sequencing services.
The company has received accreditations from the Clinical Laboratory Improvement Amendments (CLIA), the College of American Pathologists (CAP), the California Clinical Laboratory, the Pennsylvania Clinical Laboratory, the Maryland Medical Laboratory, the New York State Clinical Laboratory and the Rhode Island Laboratory. Its strategic partnership with Helio Health aims to help the company commercialise tests for blood-based early cancer detection.
Fulgent Genetics Inc. stock began trading on the NASDAQ in 2016 under the ticker symbol FLGT.
You can track the FLGT share value and price history live at http://capital.com.
Industry: | Medical & Diagnostic Laboratories |
4399 Santa Anita Ave
EL MONTE
CALIFORNIA 91731
US
Income Statement
- Annual
- Quarterly
News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com